Filing Details
- Accession Number:
- 0001140361-12-008136
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-02-14 12:00:00
- Reporting Period:
- 2011-04-21
- Filing Date:
- 2012-02-14
- Accepted Time:
- 2012-02-14 16:08:49
- Original Submission Date:
- 2011-04-21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1240656 | H Joseph Smith | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Svp, Bus Dev And Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-04-21 | 648 | $9.08 | 5,022 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-04-21 | 648 | $31.50 | 4,374 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-04-21 | 648 | $0.00 | 648 | $9.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
44,352 | 2015-04-27 | No | 4 | M | Direct |
Footnotes
- The transaction reported on this Form 4/A was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2010.
- This is an additional transaction that was excluded from the Form 4 that was filed with the U.S. Securities and Exchange Commission on April 21, 2011.
- Corrects the amount of securities beneficially owned following the reported transaction as reported on a Form 4 filed with the U.S. Securities and Exchange Commission on April 21, 2011.
- The stock option grant is 100% vested and exercisable.